Patients with EGFR Mutation Should Postpone Brain Radiation for CNS Metastases: Pro and Con

Commentary Regarding Immune Checkpoint Inhibitors

Q&A with Jamie E. Chaft, MD, Regarding the ALCHEMIST Platform

Utility and Controversies Surrounding Use of New Techniques in Radiotherapy

IASLC WCLC 2017 Presidential Symposium Presents Leading Lung Cancer Research

National Cancer Institute Adds Latest Clinical Trial to the ALCHEMIST Platform

Evolution in Treatment of Brain Metastases in Mutation-Driven Non-Small Cell Lung Cancer

New Strategy for Tobacco Regulation

Role of Allied Health Professionals in the Multidisciplinary Lung Cancer Team

Exploring the Potential of Immuno-oncology Combination Therapy

Proton-Beam Therapy Versus Photon-Beam Therapy: The Debate Continues

Q & A with Yi-Long Wu, MD